LADA prevalence estimation and insulin dependency during follow-up

Yongsoo Park, Sangmo Hong, Leejin Park, Jungtaek Woo, Sei-Hyun Baik, Munsuk Nam, Kwanwoo Lee, Youngseol Kim

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Latent autoimmune diabetes in adults (LADA) is a form of autoimmune-mediated diabetes in adults, usually defined by GAD autoantibody positivity. Few epidemiological surveys on LADA in Asians did not come to a conclusive answer regarding prevalence and incidence, because of different criteria used in patient ascertainment. Methods: We estimated LADA prevalence in a recent type 2 diabetes cohort by the positivity of circulating autoantibodies to pancreatic islet cell antigens (GAD, IA-2 and zinc transporter 8 (ZnT8)) applying a comparable Caucasian criteria. We then observed the development of insulin dependency prospectively for 36 months. Results: Applying the European NIRAD LADA group criteria, we found a high prevalence of LADA (4.4%) in Korean patients with phenotypic type 2 diabetes. This high prevalence of LADA in Korea is noteworthy since the previous population-based LADA prevalence survey reported low prevalence (1.7%). When we consider the low-titre GAD antibodies and the low prevalence of multiple autoantibodies, however, increased LADA prevalence does not necessarily mean increase in future insulin dependency. After 36 months of follow-up, only 3 of 39 patients who were initially classified as LADA have become insulin-dependent. Those three were all positive for multiple autoantibodies (GAD, IA-2 and zinc transporter 8 antibody). Other features of insulin secretion or insulin resistance did not determine future insulin necessity. Conclusions: Although the LADA prevalence estimated by anti-GAD positivity appeared to increase, the true insulin dependency evidenced by multiple antibody positivity did not increase in Korea.

Original languageEnglish
Pages (from-to)975-979
Number of pages5
JournalDiabetes/Metabolism Research and Reviews
Volume27
Issue number8
DOIs
Publication statusPublished - 2011 Nov 1

Fingerprint

Insulin
Autoantibodies
Korea
Islets of Langerhans
Type 2 Diabetes Mellitus
Antibodies
Latent Autoimmune Diabetes in Adults
Histocompatibility Antigens Class II
Type 1 Diabetes Mellitus
Insulin Resistance
Incidence
Population

Keywords

  • Incidence
  • Insulin dependency
  • LADA
  • Multiple autoantibody positivity
  • Prevalence

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

LADA prevalence estimation and insulin dependency during follow-up. / Park, Yongsoo; Hong, Sangmo; Park, Leejin; Woo, Jungtaek; Baik, Sei-Hyun; Nam, Munsuk; Lee, Kwanwoo; Kim, Youngseol.

In: Diabetes/Metabolism Research and Reviews, Vol. 27, No. 8, 01.11.2011, p. 975-979.

Research output: Contribution to journalArticle

Park, Y, Hong, S, Park, L, Woo, J, Baik, S-H, Nam, M, Lee, K & Kim, Y 2011, 'LADA prevalence estimation and insulin dependency during follow-up', Diabetes/Metabolism Research and Reviews, vol. 27, no. 8, pp. 975-979. https://doi.org/10.1002/dmrr.1278
Park, Yongsoo ; Hong, Sangmo ; Park, Leejin ; Woo, Jungtaek ; Baik, Sei-Hyun ; Nam, Munsuk ; Lee, Kwanwoo ; Kim, Youngseol. / LADA prevalence estimation and insulin dependency during follow-up. In: Diabetes/Metabolism Research and Reviews. 2011 ; Vol. 27, No. 8. pp. 975-979.
@article{2b892d956cdd4733a16706fa0f187bbe,
title = "LADA prevalence estimation and insulin dependency during follow-up",
abstract = "Latent autoimmune diabetes in adults (LADA) is a form of autoimmune-mediated diabetes in adults, usually defined by GAD autoantibody positivity. Few epidemiological surveys on LADA in Asians did not come to a conclusive answer regarding prevalence and incidence, because of different criteria used in patient ascertainment. Methods: We estimated LADA prevalence in a recent type 2 diabetes cohort by the positivity of circulating autoantibodies to pancreatic islet cell antigens (GAD, IA-2 and zinc transporter 8 (ZnT8)) applying a comparable Caucasian criteria. We then observed the development of insulin dependency prospectively for 36 months. Results: Applying the European NIRAD LADA group criteria, we found a high prevalence of LADA (4.4{\%}) in Korean patients with phenotypic type 2 diabetes. This high prevalence of LADA in Korea is noteworthy since the previous population-based LADA prevalence survey reported low prevalence (1.7{\%}). When we consider the low-titre GAD antibodies and the low prevalence of multiple autoantibodies, however, increased LADA prevalence does not necessarily mean increase in future insulin dependency. After 36 months of follow-up, only 3 of 39 patients who were initially classified as LADA have become insulin-dependent. Those three were all positive for multiple autoantibodies (GAD, IA-2 and zinc transporter 8 antibody). Other features of insulin secretion or insulin resistance did not determine future insulin necessity. Conclusions: Although the LADA prevalence estimated by anti-GAD positivity appeared to increase, the true insulin dependency evidenced by multiple antibody positivity did not increase in Korea.",
keywords = "Incidence, Insulin dependency, LADA, Multiple autoantibody positivity, Prevalence",
author = "Yongsoo Park and Sangmo Hong and Leejin Park and Jungtaek Woo and Sei-Hyun Baik and Munsuk Nam and Kwanwoo Lee and Youngseol Kim",
year = "2011",
month = "11",
day = "1",
doi = "10.1002/dmrr.1278",
language = "English",
volume = "27",
pages = "975--979",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - LADA prevalence estimation and insulin dependency during follow-up

AU - Park, Yongsoo

AU - Hong, Sangmo

AU - Park, Leejin

AU - Woo, Jungtaek

AU - Baik, Sei-Hyun

AU - Nam, Munsuk

AU - Lee, Kwanwoo

AU - Kim, Youngseol

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Latent autoimmune diabetes in adults (LADA) is a form of autoimmune-mediated diabetes in adults, usually defined by GAD autoantibody positivity. Few epidemiological surveys on LADA in Asians did not come to a conclusive answer regarding prevalence and incidence, because of different criteria used in patient ascertainment. Methods: We estimated LADA prevalence in a recent type 2 diabetes cohort by the positivity of circulating autoantibodies to pancreatic islet cell antigens (GAD, IA-2 and zinc transporter 8 (ZnT8)) applying a comparable Caucasian criteria. We then observed the development of insulin dependency prospectively for 36 months. Results: Applying the European NIRAD LADA group criteria, we found a high prevalence of LADA (4.4%) in Korean patients with phenotypic type 2 diabetes. This high prevalence of LADA in Korea is noteworthy since the previous population-based LADA prevalence survey reported low prevalence (1.7%). When we consider the low-titre GAD antibodies and the low prevalence of multiple autoantibodies, however, increased LADA prevalence does not necessarily mean increase in future insulin dependency. After 36 months of follow-up, only 3 of 39 patients who were initially classified as LADA have become insulin-dependent. Those three were all positive for multiple autoantibodies (GAD, IA-2 and zinc transporter 8 antibody). Other features of insulin secretion or insulin resistance did not determine future insulin necessity. Conclusions: Although the LADA prevalence estimated by anti-GAD positivity appeared to increase, the true insulin dependency evidenced by multiple antibody positivity did not increase in Korea.

AB - Latent autoimmune diabetes in adults (LADA) is a form of autoimmune-mediated diabetes in adults, usually defined by GAD autoantibody positivity. Few epidemiological surveys on LADA in Asians did not come to a conclusive answer regarding prevalence and incidence, because of different criteria used in patient ascertainment. Methods: We estimated LADA prevalence in a recent type 2 diabetes cohort by the positivity of circulating autoantibodies to pancreatic islet cell antigens (GAD, IA-2 and zinc transporter 8 (ZnT8)) applying a comparable Caucasian criteria. We then observed the development of insulin dependency prospectively for 36 months. Results: Applying the European NIRAD LADA group criteria, we found a high prevalence of LADA (4.4%) in Korean patients with phenotypic type 2 diabetes. This high prevalence of LADA in Korea is noteworthy since the previous population-based LADA prevalence survey reported low prevalence (1.7%). When we consider the low-titre GAD antibodies and the low prevalence of multiple autoantibodies, however, increased LADA prevalence does not necessarily mean increase in future insulin dependency. After 36 months of follow-up, only 3 of 39 patients who were initially classified as LADA have become insulin-dependent. Those three were all positive for multiple autoantibodies (GAD, IA-2 and zinc transporter 8 antibody). Other features of insulin secretion or insulin resistance did not determine future insulin necessity. Conclusions: Although the LADA prevalence estimated by anti-GAD positivity appeared to increase, the true insulin dependency evidenced by multiple antibody positivity did not increase in Korea.

KW - Incidence

KW - Insulin dependency

KW - LADA

KW - Multiple autoantibody positivity

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=80855131131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855131131&partnerID=8YFLogxK

U2 - 10.1002/dmrr.1278

DO - 10.1002/dmrr.1278

M3 - Article

VL - 27

SP - 975

EP - 979

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 8

ER -